SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

GRAZI, Gian Luca
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.446
AS - Asia 5.185
EU - Europa 1.693
SA - Sud America 1.343
Continente sconosciuto - Info sul continente non disponibili 522
AF - Africa 155
OC - Oceania 12
Totale 15.356
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.112
SG - Singapore 2.172
BR - Brasile 1.020
CN - Cina 770
HK - Hong Kong 600
VN - Vietnam 538
IT - Italia 516
BD - Bangladesh 342
FI - Finlandia 227
RU - Federazione Russa 204
ID - Indonesia 182
JP - Giappone 176
FR - Francia 172
DE - Germania 153
CA - Canada 141
GB - Regno Unito 138
IN - India 113
AR - Argentina 104
MX - Messico 100
UA - Ucraina 59
CO - Colombia 57
NL - Olanda 54
EC - Ecuador 52
TR - Turchia 51
ZA - Sudafrica 51
AT - Austria 48
IQ - Iraq 40
CL - Cile 31
PK - Pakistan 28
PY - Paraguay 27
VE - Venezuela 27
SE - Svezia 25
ES - Italia 24
MA - Marocco 23
SA - Arabia Saudita 23
MY - Malesia 20
UZ - Uzbekistan 20
JM - Giamaica 19
KE - Kenya 18
CR - Costa Rica 15
DZ - Algeria 15
PH - Filippine 14
TN - Tunisia 13
AE - Emirati Arabi Uniti 10
AZ - Azerbaigian 10
PE - Perù 10
TT - Trinidad e Tobago 10
AU - Australia 9
DO - Repubblica Dominicana 9
JO - Giordania 9
BO - Bolivia 8
CH - Svizzera 8
EG - Egitto 8
LT - Lituania 8
NP - Nepal 8
PL - Polonia 8
HN - Honduras 7
IE - Irlanda 7
UY - Uruguay 7
AL - Albania 6
BH - Bahrain 6
IL - Israele 6
KR - Corea 6
SV - El Salvador 6
TW - Taiwan 6
BY - Bielorussia 5
ET - Etiopia 5
KZ - Kazakistan 5
SN - Senegal 5
BE - Belgio 4
OM - Oman 4
DK - Danimarca 3
EE - Estonia 3
GT - Guatemala 3
LB - Libano 3
MO - Macao, regione amministrativa speciale della Cina 3
NG - Nigeria 3
NI - Nicaragua 3
NZ - Nuova Zelanda 3
TH - Thailandia 3
AM - Armenia 2
AO - Angola 2
BA - Bosnia-Erzegovina 2
BB - Barbados 2
BG - Bulgaria 2
BS - Bahamas 2
CZ - Repubblica Ceca 2
EU - Europa 2
GP - Guadalupe 2
GR - Grecia 2
HT - Haiti 2
HU - Ungheria 2
IR - Iran 2
KW - Kuwait 2
LC - Santa Lucia 2
LV - Lettonia 2
PA - Panama 2
PR - Porto Rico 2
PS - Palestinian Territory 2
PT - Portogallo 2
Totale 14.801
Salva come PNG Salva come JPEG
Città #
Singapore 1.138
Ashburn 826
Santa Clara 804
San Jose 770
Hong Kong 597
Council Bluffs 473
Fairfield 274
Beijing 273
Helsinki 219
Ho Chi Minh City 190
Tokyo 171
Chandler 165
Lauterbourg 148
New York 146
Jakarta 133
Hanoi 122
Houston 113
Woodbridge 103
Los Angeles 88
São Paulo 82
Seattle 75
Dallas 74
Wilmington 74
Princeton 72
Mexico City 71
Toronto 68
Chicago 65
Cambridge 58
Milan 57
Moscow 57
Rome 54
Orem 48
Boardman 46
San Diego 46
Nuremberg 42
London 41
Shanghai 41
Ann Arbor 40
Rio de Janeiro 32
Buffalo 31
Haiphong 23
Jacksonville 23
Salt Lake City 23
Vienna 23
Baghdad 22
Belo Horizonte 21
Montreal 21
Quito 21
Chennai 20
Da Nang 20
San Francisco 20
Brooklyn 19
Curitiba 19
Medellín 19
Frankfurt am Main 18
Guangzhou 18
Naples 18
Porto Alegre 18
Tashkent 18
Bologna 17
Brasília 17
Newark 17
Portsmouth 17
Atlanta 16
Biên Hòa 16
Falkenstein 16
Falls Church 16
Ferrara 14
Guayaquil 14
Nairobi 14
Caracas 13
Dhaka 13
Fortaleza 13
Johannesburg 13
Manchester 13
Turin 13
Bari 12
Guarulhos 12
Istanbul 12
Mumbai 12
Buenos Aires 11
Phoenix 11
San José 11
Tampa 11
Amsterdam 10
Asunción 10
Campinas 10
Charlotte 10
Hangzhou 10
Salvador 10
Santiago 10
Washington 10
Amman 9
Ankara 9
Baku 9
Hải Dương 9
Juiz de Fora 9
Kingston 9
Kuala Lumpur 9
New Delhi 9
Totale 8.807
Salva come PNG Salva come JPEG
Nome #
MiR-199a-3p regulates mTOR and c-Met to influence the doxorubicin sensitivity of human hepatocarcinoma cells 208
MiR-122/cyclin G1 interaction modulates p53 activity and affects doxorubicin sensitivity of human hepatocarcinoma cells 179
Tumor Regression Grade After Neoadjuvant Chemoradiation and Surgery for Low Rectal Cancer Evaluated by Multiple Correspondence Analysis: Ten Years as Minimum Follow-up 177
MicroRNA-221 targets Bmf in hepatocellular carcinoma and correlates with tumor multifocality 171
An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics 166
The Immune Landscape of Cancer 159
A case report of giant hepatic hemangioma spontaneous regression in adult, non-cirrhotic patient and literature review 151
Adjuvant, adoptive immunotherapy with tumor infiltrating lymphocytes plus interleukin-2 after radical hepatic resection for colorectal liver metastases: 5-year analysis 147
A Pan-Cancer Analysis of Enhancer Expression in Nearly 9000 Patient Samples 141
Oncogenic Signaling Pathways in The Cancer Genome Atlas 137
A Comprehensive Pan-Cancer Molecular Study of Gynecologic and Breast Cancers 136
Early onset aggressive hereditary amyloidosis: report of an Italian family with TTR Arg47 mutation. 134
The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma 126
ALPPS for primary and secondary liver tumors 123
A Pan-Cancer Analysis Reveals High-Frequency Genetic Alterations in Mediators of Signaling by the TGF-β Superfamily 121
Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer 118
Criteria for diagnosing benign portal vein thrombosis in the assessment of patients with cirrhosis and hepatocellular carcinoma for liver transplantation 118
Cholangiocarcinoma landscape in Europe: diagnostic, prognostic and therapeutic insights from the ENSCCA Registry 118
Perspective on Oncogenic Processes at the End of the Beginning of Cancer Genomics 115
Scalable Open Science Approach for Mutation Calling of Tumor Exomes Using Multiple Genomic Pipelines 112
Comparative Molecular Analysis of Gastrointestinal Adenocarcinomas 111
Comprehensive Characterization of Cancer Driver Genes and Mutations 110
Expression of connective tissue growth factor is a prognostic marker for patients with intrahepatic cholangiocarcinoma 109
Curative versus palliative treatments for recurrent hepatocellular carcinoma: a multicentric weighted comparison 108
Comprehensive Molecular Characterization of the Hippo Signaling Pathway in Cancer 106
Genomic and Functional Approaches to Understanding Cancer Aneuploidy 103
Machine Learning Identifies Stemness Features Associated with Oncogenic Dedifferentiation 103
Anti-HBs re-seroconversion after liver transplantation in a patient with past HBV infection receiving a HBsAg positive graft 102
Comprehensive Analysis of Alternative Splicing Across Tumors from 8,705 Patients 101
Pathogenic Germline Variants in 10,389 Adult Cancers 101
A Novel Nomogram to Predict the Prognosis of Patients Undergoing Liver Resection for Neuroendocrine Liver Metastasis: an Analysis of the Italian Neuroendocrine Liver Metastasis Database 100
Performance of comprehensive complication index and clavien‐dindo complication scoring system in liver surgery for hepatocellular carcinoma 99
Partial necrosis on hepatocellular carcinoma nodules facilitates tumor recurrence after liver transplantation 98
DCLK1, a putative novel stem cell marker in human cholangiocarcinoma 98
A new priority policy for patients with hepatocellular carcinoma awaiting liver transplantation within the model for end-stage liver disease system 97
Hepatocellular carcinoma surgical and oncological trends in a national multicentric population: the HERCOLES experience 97
Wnt3a/b-Catenin signaling conditions differentiation of partially exhausted T-effector cells in human cancers 97
Genetically driven CD39 expression shapes human tumor-infiltrating CD8+ T-cell functions 95
Renewed considerations on the utility (or the futility) of hepatic resections for breast cancer liver metastases 95
Liver transplantation for hepatocellular carcinoma: further considerations on selection criteria 94
The Impact of Hospital Volume on Failure to Rescue after Liver Resection for Hepatocellular Carcinoma: Analysis from the HE.RC.O.LE.S. Italian Registry 93
Harm and benefits of primary liver resection and salvage transplantation for hepatocellular carcinoma 93
Italian Clinical Practice Guidelines on Cholangiocarcinoma – Part I: Classification, diagnosis and staging 92
The FXR agonist obeticholic acid inhibits the cancerogenic potential of human cholangiocarcinoma 91
Metformin exerts anti-cancerogenic effects and reverses epithelial-to-mesenchymal transition trait in primary human intrahepatic cholangiocarcinoma cells 91
Impact of model for end-stage liver disease (MELD) score on prognosis after hepatectomy for hepatocellular carcinoma on cirrhosis 90
Daclizumab and alemtuzumab as induction agents in adult intestinal and multivisceral transplantation: rejection and infection rates in 40 recipients during the early postoperative period 90
The actin modulator hMENA regulates GAS6-AXL axis and pro-tumor cancer/stromal cell cooperation 90
Effect of ischemic preconditioning in whole liver transplantation from deceased donors. A pilot study 90
Primary leiomyoma of the liver in an immunocompetent patient 89
Laboratory test variability and Model for End-Stage Liver Disease score calculation: effect on liver allocation and proposal for adjustment 89
Forcing ATGL expression in hepatocarcinoma cells imposes glycolytic rewiring through PPAR-α/p300-mediated acetylation of p53 88
Down-staging of hepatocellular carcinoma prior to liver transplantation: the power of selection 88
lncRNA Epigenetic Landscape Analysis Identifies EPIC1 as an Oncogenic lncRNA that Interacts with MYC and Promotes Cell-Cycle Progression in Cancer 87
Key components of a hepatobiliary surgery curriculum for general surgery residents: results of the FULCRUM International Delphi consensus 85
Pan-cancer Alterations of the MYC Oncogene and Its Proximal Network across the Cancer Genome Atlas 85
The Impact of Postoperative Ascites on Survival After Surgery for Hepatocellular Carcinoma: a National Study 85
Current status of liver surgery for non-colorectal non-neuroendocrine liver metastases: the NON.LI.MET. Italian Society for Endoscopic Surgery and New Technologies (SICE) and Association of Italian Surgeons in Europe (ACIE) collaborative international survey 84
Adjuvant systemic chemotherapy after putative curative resection of colorectal liver and lung metastases 84
Evolution of pancreatectomy with en bloc venous resection for pancreatic cancer in Italy. Retrospective cohort study on 425 cases in 10 pancreatic referral units 84
Liver resection for hepatocellular carcinoma on cirrhosis: a univariate and multivariate analysis of risk factors for intrahepatic recurrence 83
The pattern of hMENA isoforms is regulated by TGF-β1 in pancreatic cancer and may predict patient outcome 83
Association of polygenic risk score and bacterial toxins at screening colonoscopy with colorectal cancer progression: A multicenter case-control study 83
Trends in perioperative outcome after hepatic resection: analysis of 1500 consecutive unselected cases over 20 years 82
Comparison of recurrence of hepatocellular carcinoma after resection in patients with cirrhosis to its occurrence in a surveilled cirrhotic population 82
Comparison between the fifth and sixth editions of the AJCC/UICC TNM staging systems for hepatocellular carcinoma: multicentric study on 393 cirrhotic resected patients 82
Diffusion, outcomes and implementation of minimally invasive liver surgery: a snapshot from the I Go MILS (Italian Group of Minimally Invasive Liver Surgery) Registry 82
Multiple hepatocellular carcinoma: Long-term outcomes following resection beyond actual guidelines. An Italian multicentric retrospective study 82
Laparoscopic liver resection of hepatocellular carcinoma located in unfavorable segments: a propensity score-matched analysis from the I Go MILS (Italian Group of Minimally Invasive Liver Surgery) Registry 80
FGFR2 fusion proteins drive oncogenic transformation of mouse liver organoids towards cholangiocarcinoma 80
Efficacy of MELD score in predicting survival after liver retransplantation 79
Perspectives from Italy during the COVID-19 pandemic: nationwide survey-based focus on minimally invasive HPB surgery 79
Multicohort and cross-platform validation of a prognostic Wnt signature in colorectal cancer 79
Benchmarking postoperative outcomes after open liver surgery for cirrhotic patients with hepatocellular carcinoma in a national cohort 79
Hepatitis C virus recurrence after liver transplantation: a 10-year evaluation 78
Impact of a goal-directed fluid therapy on length of hospital stay and costs of hepatobiliarypancreatic surgery: A prospective observational study 78
Multicentre evaluation of case volume in minimally invasive hepatectomy 76
Psychological Adaptation and Quality of Life of Adult Intestinal Transplant Recipients: University of Bologna Experience 76
Outcome of Right Hepatectomies in Patients Older Than 70 Years 76
Aberrant Notch3 and Notch4 expression in human hepatocellular carcinoma 75
Associated benign liver tumors in idiopathic granulomatous hepatitis: a case report 75
Molecular Aging of Human Liver: An Epigenetic/Transcriptomic Signature 74
Long Term Follow-Up of Patients with De Novo Tumors after 1300 Liver Transplantations: A Case-Control Study 74
Improving the outcome of liver transplantation with very old donors with updated selection and management criteria 74
Liver allocation for hepatocellular carcinoma: a European Center policy in the pre-MELD era 73
Robotic Liver Resections: Application of Difficulty Score Systems to an Initial Experience. Is a Specific Robotic Difficulty Score Necessary? 73
Systemic fungemia and hepatic localizations of Fusarium solani in a liver transplanted patient: An emerging fungal agent 72
Recommendations for management of patients with neuroendocrine liver metastases 72
Italian Clinical Practice Guidelines on Cholangiocarcinoma - Part II: Treatment 72
Six score systems to evaluate candidates with advanced cirrhosis for orthotopic liver transplant: which is the winner? 71
A bioluminescent mouse model of proliferation to highlight early stages of pancreatic cancer: A suitable tool for preclinical studies 71
Histological recurrent hepatitis C after liver transplantation: Outcome and role of retransplantation 71
Blood transfusions and steatohepatitis are independent risk factors for complications following liver resection for colorectal cancer liver metastases 70
Coping strategies in intestinal transplantation 70
Analysis of factors affecting recurrence of hepatocellular carcinoma after liver transplantation with a special focus on inflammation markers 70
Changes in the surgical approach to hilar cholangiocarcinoma during an 18-year period in a Western single center 70
Liver and partial atrium transplantation for chronic Budd-Chiari syndrome 70
The largest western experience on salvage hepatectomy for recurrent hepatocellular carcinoma: propensity score-matched analysis on behalf of He.RC.O.Le.Study Group 70
Is it time to develop a robotic difficulty score system? 69
Identification of miR-31-5p, miR-141-3p, miR-200c-3p, and GLT1 as human liver aging markers sensitive to donor-recipient age-mismatch in transplants 69
Totale 9.673
Salva come PNG Salva come JPEG
Categoria #
all - tutte 127.761
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 127.761
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022614 0 114 7 6 13 11 127 73 41 22 58 142
2022/2023798 75 45 8 50 46 398 9 41 64 4 35 23
2023/2024498 38 79 38 22 24 18 14 19 19 8 30 189
2024/20253.203 115 49 326 3 378 394 59 129 402 838 238 272
2025/20268.560 467 344 853 1.016 934 318 679 507 1.024 1.285 590 543
2026/20271.022 422 600 0 0 0 0 0 0 0 0 0 0
Totale 15.356